OMID Holdings, Inc. OMID reported an initial financial review of its fourth-quarter operations.
“OMID’s financial highlights, which detail record revenues for both the fourth quarter and the year of 2021, convey a narrative of profitable growth organically-fueled by business operations,” said Adam Frank, chairman and CEO of the New Jersey-based companty.
“We inherited an ‘Accumulated Deficit’ as a direct result of our reverse merger with AVOP, and I’m proud to say that we’ve converted this term on our balance sheet into ‘Retained Earnings’ - a goal of mine since day one. Having officially pulled this off, our future ambitions begin with an uplist to the OTCQB,” Frank added.
Q4 2021 Financial Highlights
- Revenue was $1.18 million compared to $1.08 million for the third quarter of 2021, a 9% improvement. Quarterly revenue increased by $690,263 or 141% year-over-year.
- Gross profit was $590,749 compared to $488,397 for the prior period, a 21% improvement. In addition, gross profit increased by $303,663 or 106% year-over-year.
- Net income, before income taxes, was $469,034, compared to $422,729 for the previous quarter, an 11% improvement. Year-over-year, net income rose by $228,510 or 95% from $240,524 for in the prior period.
FY 2021 Financial Highlights
- Revenue was $2.77 million, up by 108% year-over-year.
- Gross profit totaled $1.35 compared to $649,435 for the prior year, a 108% improvement.
- Net income, before income taxes, was $994,521, compared to $425,757 for the prior year, a 134% improvement.
Photo: Courtesy of Chris Briggs on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.